Drug Development
The new weapon against malaria’s drug resistance
Malaria parasites have now developed resistance to seven drugs; but promising new drug targets have been identified in a new University of Melbourne-led study.
Killing the malaria parasite by blocking its recycling system
A new drug candidate stops the malaria parasite breaking down waste, resulting in a fatal ‘molecular constipation', finds University of Melbourne-led study.
Starving the bacterium that causes pneumonia
By targeting an essential nutrition pathway, University of Melbourne researchers hope to develop drug targets against the bacteria that cause pneumonia
An unexpected find opens a new way to regulate blood pressure
Brain researchers at the Florey Institute and University of Melbourne discover zinc plays a role in lowering blood pressure, in what may be a new drug therapy.
New drug target for sugar-coated viruses
New research including University of Melbourne shows targeting sugar production in human cells has potential for broad-spectrum drugs against viruses.
New targets for epilepsy treatment
Associate Professor Reid is developing new drugs for epilepsy, with the view of treating a larger population of people with epilepsy.
Why are there so few drugs to treat viruses?
As coronavirus case numbers surge, University of Melbourne experts explain why we have effective drugs for bacterial diseases, but relatively few for viruses.
Q&A: How could COVID-19 drugs work and what’s out there?
Finding existing drugs that are effective against COVID-19 is the fastest way to a treatment – University of Melbourne experts explain how they might work.
Sea snail venom holds clues for diabetes treatment
A new study, that the University of Melbourne is part of, finds modified human insulin that mimics fast-acting sea snail venom is a potential diabetes treatment
Lessons for a future pandemic
Professor Peter Doherty from the University of Melbourne discusses the latest COVID-19 drug and vaccine research, and how best to prepare for future pandemic